Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

The Business of Fashion
Beauty

Eli Lilly Warns Against ‘Cosmetic’ Use of Popular Weight-Loss Drugs

“Mounjaro and Zepbound are indicated for the treatment of serious diseases; they are not approved for – and should not be used for – cosmetic weight loss,” the company said in a statement Thursday morning.
Famed for speedy weight loss, Ozempic is having far-reaching consequences.
Eli Lilly & Co. cautioned against using its popular diabetes and obesity drugs for “cosmetic weight loss." (Shutterstock)
By

Eli Lilly & Co. cautioned against using its popular diabetes and obesity drugs for “cosmetic weight loss” as off-label use of the medications has skyrocketed and shortages ensued.

“Mounjaro and Zepbound are indicated for the treatment of serious diseases; they are not approved for – and should not be used for – cosmetic weight loss,” the company said in a statement Thursday morning.

Neither drug is approved for weight loss in people who don’t have a diagnosis of type 2 diabetes or obesity. Weight-loss drugs were popularised after social media influencers on TikTok and celebrities like Elon Musk touted rival Novo Nordisk A/S’s Ozempic and Wegovy, which have similar effects. The demand prompted supply troubles, which impacted the ability of people with diabetes to get their medications.

Lilly did not outline any additional steps it is taking to prevent off-label use. The company also said it was concerned about knock-off versions of its medicines that have not been approved by the US Food and Drug Administration, some of which have been found to contain impurities.

ADVERTISEMENT

By Madison Muller


Learn more:

How Ozempic Changed the Face of Beauty

Famed for speedy weight loss, the effects of the prescription-only drug are now shifting beauty standards.

In This Article
Topics

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.

Estée Lauder’s Surprise Acquisition, Explained

The American cosmetic giant’s buyout of Ayurvedic beauty line Forest Essentials came as a surprise. By picking an under-the-radar brand it knows well, the company can show that it’s still in the M&A game without needing to outbid rivals.

view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.

Can Big Luxury Find Its New Look?

Sex sells — if anyone can figure out what sexy means in 2026. Robert Williams tracks the search for a new silhouette at Kering’s Gucci, LVMH’s Dior and more.

Estée Lauder’s Surprise Acquisition, Explained

The American cosmetic giant’s buyout of Ayurvedic beauty line Forest Essentials came as a surprise. By picking an under-the-radar brand it knows well, the company can show that it’s still in the M&A game without needing to outbid rivals.

VIEW MORE

The Business of Fashion

Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON
© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions, Privacy Policy, Cookie Policy and Accessibility Statement.